Publication Name	World Journal of Gastroenterology
Manuscript ID	5382
Country	Poland

Received	2013-09-04 16:13
Peer-Review Started	2013-09-05 08:33
To Make the First Decision	2013-11-13 14:11
Return for Revision	2013-10-15 14:07
Revised	2013-11-05 18:20
Second Decision	2013-12-05 19:25
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-12-06 12:03
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-01-06 09:52
Publish the Manuscript Online	2014-01-20 17:10

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability
Manuscript Source	Invited Manuscript
All Author List	Danuta Owczarek, Dorota Cibor, Mikołaj K Głowacki, Tomasz Rodacki and Tomasz Mach
Funding Agency and Grant Number
Corresponding Author	Danuta Owczarek, MD, PhD, Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College, Kraków, Poland 5 Śniadeckich St, 31-531 Krakow, Poland. owczarek@su.krakow.pl
Key Words	Crohn’s disease; Hypercoagulation; Risk factors; Thrombosis; Ulcerative colitis
Core Tip	Thromboembolic events (TE) in inflammatory bowel diseases (IBD) patients are often overlooked. They affect both the venous and arterial systems. The inflammatory process initiates clotting, impairs the fibrinolytic system and decreases the activity of natural anticoagulation mechanisms. Depression of anticoagulation mechanisms not only increases thrombosis, but also potentiates the inflammatory process. The objective of the present report is to demonstrate the high significance of a problem posed by hypercoagulability in IBD patients based on TE epidemiology, and to present abnormalities in the hemostatic system.
Publish Date	2014-01-20 17:10
Citation	Owczarek D, Cibor D, G?owacki MK, Rodacki T, Mach T. Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol 2014; 20(1): 53-63
URL	http://www.wjgnet.com/1007-9327/full/v20/i1/53.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i1.53

Full Article (PDF)	WJG-20-53.pdf
Full Article (Word)	WJG-20-53.doc
Manuscript File	5382-Review.docx
Answering Reviewers	5382-Answering reviewers.pdf
Copyright License Agreement	5382-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5382-Language certificate.pdf
Peer-review Report	5382-Peer review(s).pdf
Scientific Editor Work List	5382-Scientific editor work list.doc